Sigma Healthcare Ltd
ASX:SIG
Intrinsic Value
Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label. [ Read More ]
The intrinsic value of one
SIG
stock under the Base Case scenario is
1.768
AUD.
Compared to the current market price of 1.295 AUD,
Sigma Healthcare Ltd
is
Undervalued by 27%.
Sigma Healthcare Ltd's market capitalization is 2B AUD.
SIG stock price is 1.295 AUD.
SIG stock price (1.295 AUD) is 27% less than its Intrinsic Value (1.768 AUD).
SIG stock price (1.295 AUD) is 48% less than its Relative Value (2.487 AUD). Open Relative Valuation
SIG has downside potential of 15% compared to the average analyst price target.
Open Wall St Estimates
SIG has positive Gross Profit for the last twelve months.
SIG has positive Free Cash Flow for the last twelve months.
SIG's ROIC (Return on Invested Capital) has decreased in the last 3 years from 2% to 2%.
SIG's Revenue has been falling by 1% per year for the last 3 years.
SIG's Revenue has dropped by 9% over the past 12 months.
SIG's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 2%.
SIG's ROE (Return on Equity) has decreased in the last 3 years from 9% to 1%.
SIG's ROE (Return on Equity) for the past 12 months is very low and is equal to 1%.
SIG has positive Operating Income for the last twelve months.
SIG has positive Net Income for the last twelve months.
SIG's Revenue is forecast to grow at a rate of 24% per year over the next 3 years.
SIG has a very low three-year average ROE (Return on Equity): 3%. The company is not efficient at transforming stockholders' equity into net income.
SIG has a very low three-year average ROIC (Return on Invested Capital): 2%. The company is not efficient at using invested capital to generate operating income.
SIG's short-term assets (913m AUD) exceed its short-term liabilties (371m AUD).
SIG's long-term assets (1B AUD) exceed its long-term liabilties (507m AUD).
SIG has negative Net Debt. This means that the company has more cash and short-term investments (356m AUD) than debt (127m AUD).
SIG's Altman Z-Score is very high and is equal to 3.84.
SIG's D/E (Debt to Equity) is very low and is equal to 0.15.
SIG doesn't generate enough operating income (23m AUD) to safely cover interest payments on its debt (-17m AUD).
Valuation Backtest
Sigma Healthcare Ltd
Run backtest to discover the historical profit from buying and selling
SIG
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Sigma Healthcare Ltd
Balance Sheet Decomposition
Sigma Healthcare Ltd
| Current Assets | 912.5m |
| Cash & Short-Term Investments | 356.5m |
| Receivables | 320m |
| Other Current Assets | 236m |
| Non-Current Assets | 465.4m |
| Long-Term Investments | 13.6m |
| PP&E | 271.8m |
| Intangibles | 110.3m |
| Other Non-Current Assets | 69.8m |
| Current Liabilities | 371.3m |
| Accounts Payable | 353.6m |
| Other Current Liabilities | 17.7m |
| Non-Current Liabilities | 135.9m |
| Long-Term Debt | 126.8m |
| Other Non-Current Liabilities | 9m |
Earnings Waterfall
Sigma Healthcare Ltd
|
Revenue
|
3.4B
AUD
|
|
Cost of Revenue
|
-3.1B
AUD
|
|
Gross Profit
|
313.3m
AUD
|
|
Operating Expenses
|
-290.1m
AUD
|
|
Operating Income
|
23.2m
AUD
|
|
Other Expenses
|
-18.7m
AUD
|
|
Net Income
|
4.5m
AUD
|
Free Cash Flow Analysis
Sigma Healthcare Ltd
SIG Profitability Score
Profitability Due Diligence
Sigma Healthcare Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Sigma Healthcare Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
SIG Solvency Score
Solvency Due Diligence
Sigma Healthcare Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Sigma Healthcare Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SIG Price Targets Summary
Sigma Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for
SIG
is 1.107 AUD
with a low forecast of 0.788 AUD and a high forecast of 1.365 AUD.
Shareholder Return
SIG Price
Sigma Healthcare Ltd
| Average Annual Return | 6.9% |
| Standard Deviation of Annual Returns | 17.27% |
| Max Drawdown | -40% |
| Market Capitalization | 2B AUD |
| Shares Outstanding | 1 570 565 857 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Sigma Healthcare Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label. The company is headquartered in Melbourne, Victoria. The company went IPO on 2002-10-30. The firm operates over 1,200 branded and independent stores, including pharmacy retail brands, such as Amcal, Guardian, Chemist King, Discount Drug Stores, WholeLife, and PharmaSave. The firm provides a range of solutions, including Dispensary Services, Data and Technology, Health Services, Team Training, Private and Exclusive Label, Sigma Rewards, Sigma Financial Services, and Supply Network and Logistics. Its Dispensary Services provides Pharma and Sigma Ethical Partnership Program. Its Data and Technology provides e-prescription support, health opportunities and sigma performance dashboard tool. Its Health Services includes pharmacy practice support, LEAPP Foundation program, PSS Sleep Apnoea program and sigma dose administration aid program. Its Team Training involves Sigma Online Training Platform.
Contact
IPO
Employees
Officers
The intrinsic value of one
SIG
stock under the Base Case scenario is
1.768
AUD.
Compared to the current market price of 1.295 AUD,
Sigma Healthcare Ltd
is
Undervalued by 27%.
You don't have any saved screeners yet
